Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Apr
2
2019
Federal Circuit Finds Endo Method Of Treatment Claims Satisfy 35 USC 101 Foley & Lardner LLP
Apr
1
2019
Bridging the Weeks by Gary DeWaal: March 18 – 29 and April 1, 2019 (Programmer’s Trial; Trade Reporting Headaches; Food Giants Settle Manipulation Enforcement Action) Katten
Apr
1
2019
FDA Silent on CBD Regulation at Cosmetics Conference, But Legislation May Be Imminent Mintz
Apr
1
2019
District Court Decision Rejects Commerce Clause Challenge to Missouri’s Retailer Wine Shipping Laws McDermott Will & Schulte LLP
Apr
1
2019
Public Consultation on EFSA’s Draft Assessment of 5 Phthalates Underway Keller and Heckman LLP
Apr
1
2019
U.S. Supreme Court to Consider Whether Courts Must Defer to an Agency’s Interpretation of its Regulations – a Judicial Policy That Recently Resulted in Dismissal of Litigation Over ‘No Sugar Added’ Claims on 100% Juices Keller and Heckman LLP
Mar
30
2019
Second Circuit Affirms “Snap” Removal Practice Sheppard, Mullin, Richter & Hampton LLP
Mar
29
2019
Endo v. Teva – Correlation Diagnostic Plus Treatment is Patent Eligible under s. 101
Mar
29
2019
OH SNAP! Supreme Court to Take on Meaning of Key FOIA Exemption Sheppard, Mullin, Richter & Hampton LLP
Mar
29
2019
FDA’s Premarket Voluntary Plant Biotechnology Consultation Program Provides Opportunity For Developers Bergeson & Campbell, P.C.
Mar
29
2019
FDA Announces Enforcement Discretion for Certain Commodities Related to Produce Safety Rule Keller and Heckman LLP
Mar
29
2019
Possession Of A Medical Marijuana Card Alone Does Not Prove Marijuana Use, Appeals Court Holds Jackson Lewis P.C.
Mar
29
2019
ISO Publishes Standard on Matrix of Properties and Measurement Techniques for Graphene and Related 2D Materials Bergeson & Campbell, P.C.
Mar
29
2019
Learned Intermediary Doctrine Protects Pharmacy from Liability for Failure to Warn of Prescription Drug Side Effects Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
28
2019
New Jersey Legislature Cancels Vote to Legalize Recreational Marijuana Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
28
2019
California Jury Awards $80 Million Verdict in Glyphosate Case Keller and Heckman LLP
Mar
28
2019
Pharmacies: DOJ Wins TRO to Immediately Suspend Registration for Controlled Substances
Mar
27
2019
FDA’s Evolving “Compliance Policy” for Deemed Tobacco Products: What it Means for Your Business Keller and Heckman LLP
Mar
27
2019
MillerCoors Turns to Lanham Act to Nip Rival’s Ads in the “Bud” Bilzin Sumberg
Mar
27
2019
Novartis Hit with $1.5M Whistleblower Suit, Avoids Punitive Damages Stark & Stark
Mar
27
2019
KIND Petitions FDA to Update Nutrient Content Claim Regulations Keller and Heckman LLP
Mar
26
2019
EPA Updates New RT25 Data to Help Beekeepers and Farmers Protect Pollinators Bergeson & Campbell, P.C.
Mar
26
2019
Soda Tax Debate Continues Keller and Heckman LLP
Mar
25
2019
NNI Webinar Registration Available: Drivers of NanoEHS Research Bergeson & Campbell, P.C.
Mar
25
2019
The Future of Direct Shipping McDermott Will & Schulte LLP
Mar
25
2019
The Miraculous Mushroom: How BioTech Regulations Influence Innovation Polsinelli PC
Mar
25
2019
Trademarks and Hemp-Derived Cannabidiol: Brand Protection for CBD Products Ward and Smith, P.A.
Mar
25
2019
Ned Sharpless Named New Acting FDA Commissioner Keller and Heckman LLP
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters